Scientists at The Scripps Research Institute (TSRI) have given new superpowers to the antibiotic vancomycin — an advance that could eliminate the threat of antibiotic-resistant infections for years to come.
The researchers, led by Dale Boger, co-chair of the TSRI department of chemistry, discovered a way to structurally modify vancomycin to make an already-powerful version of the antibiotic even more potent.
"Doctors could use this modified form of vancomycin without fea
All access premium subscription
This content requires a subscription to Feedstuffs in order to access. If you are a paid subscriber, use your email and password to Log In now.
Current Feedstuffs Subscribers: Online and mobile access are now included at no charge to you. To read this article, use your subscriber email and password to log-in to your account (or contact us for assistance in updating your account.)
Not Currently a Subscriber: Subscribe NOW to Feedstuffs and receive our print and/or digital publications, enewsletters and premium online content. Visit Feedstuffs.com and click on Subscribe at the top of the page for more information.
SUBSCRIBE NOW https://circulation.feedstuffs.com/Publications.aspx
TO RENEW YOUR SUBSCRIPTION https://circulation.feedstuffs.com/SubscriptionOffers.aspx